LinkedIn Profile

Access Aptevo Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:apvo 10701943 Apr 21st, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 20th, 2024 10:55PM Apr 20th, 2024 10:55PM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics
nasdaq:apvo 10701943 Apr 20th, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 19th, 2024 10:48PM Apr 20th, 2024 04:34PM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics
nasdaq:apvo 10701943 Apr 19th, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 18th, 2024 10:55PM Apr 18th, 2024 10:55PM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics
nasdaq:apvo 10701943 Apr 18th, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 17th, 2024 10:57PM Apr 18th, 2024 05:54PM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics
nasdaq:apvo 10701943 Apr 17th, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 16th, 2024 10:40PM Apr 17th, 2024 02:17PM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics
nasdaq:apvo 10701943 Apr 16th, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 15th, 2024 10:41PM Apr 16th, 2024 10:34AM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics
nasdaq:apvo 10701943 Apr 15th, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 14th, 2024 10:41PM Apr 15th, 2024 04:15PM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics
nasdaq:apvo 10701943 Apr 14th, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 13th, 2024 10:36PM Apr 14th, 2024 10:34AM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics
nasdaq:apvo 10701943 Apr 13th, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 12th, 2024 10:26PM Apr 13th, 2024 11:02AM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics
nasdaq:apvo 10701943 Apr 12th, 2024 12:00AM Aptevo Therapeutics Inc 3.1K 64.00 Open Apr 11th, 2024 10:29PM Apr 12th, 2024 07:57AM Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology. Open Open 2401 4th Avenue, Suite 1050 Seattle WA US 98101 Aptevo Therapeutics

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.